SPOTLIGHT -
VISTAKON vistas: The VISTAKON unit of Johnson & Johnson may spend more than $30 million to build a new research and development center in Jacksonville, FL. The center, to be completed in September 2003, will develop new VISTAKON products.
Comparing ChatGPT 3.5, Microsoft Bing, and Google Gemini in diagnosing cases of neuro-ophthalmology
(EyePod) From idea to impact: Navigating ophthalmic innovation
The role of multimodal imaging in ocular trauma
EyePod: Modifier Gene Therapy: What is it?
Blog: Managing patients with MGD and Demodex blepharitis
Treatment challenges in patients with nAMD